Google-​Mutter Alphabet steigert Gewinn und Erlöse über­raschend stark

Valeant Pharmaceuticals To Participate At Healthcare Conferences

Montag, 13.02.2017 23:00 von PR Newswire

PR Newswire

LAVAL, Quebec, Feb. 13, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that Joseph C. Papa, Chairman and CEO, will participate in the following healthcare conferences:

  • 2017 RBC Capital Markets' Healthcare Conference on Thursday, February 23, 2017 at 9:00 a.m. ET at the New York Palace Hotel; and,

  • Barclays Global Healthcare Conference on Wednesday, March 15, 2017 at 8:30 a.m. ET at the Loews Miami Beach Hotel.

A live webcast and audio archive of the events will be available on Valeant's Investor Relations website and via this URL:

About Valeant

Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, gastrointestinal disorders, eye health, neurology and branded generics. More information about Valeant and forward looking statements can be found at

Contact Information:

Elif McDonald
877-281-6642 (toll free)

Renée Soto
Chris Kittredge/Jared Levy
Sard Verbinnen & Co.

To view the original version on PR Newswire, visit:

SOURCE Valeant Pharmaceuticals International, Inc.